France · 
Who invested in En Carta Diagnostics?
En Carta Diagnostics's investors include Bpifrance, Ring Capital and 50 Partners.
France · Seed startup
Who invested in En Carta Diagnostics
Funding summaryUpdated 26 Oct 2026
$3.4Mraised across 1 round since 2026, from 1 source
- Latest round
- Seed, $3.4MJul 2026
- Investors
- 3
The rounds
- Jul 2026
Founders and team
From En Carta Diagnostics's own website: 2 founders, 4 on the team.
Guillaume HorreardCEO & Co-founder
Margot KarlikowCTO & Co-founder
- Laboratory Technician& Operations Coordinator
- Kamila DelaneyHead of Research & Innovation
- Agata WawszczykSenior Scientist / Microbiologist
- Maxence AmoryJunior Product Development Engineer
AdvisersAlexander GreenKeith Pardee
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about En Carta Diagnostics
How much has En Carta Diagnostics raised?
En Carta Diagnostics has raised $3.4M across 1 round since 2026.
When did En Carta Diagnostics last raise?
En Carta Diagnostics's most recent round was a Seed of $3.4M in Jul 2026.
What was En Carta Diagnostics's biggest round?
Its most recent round, $3.4M in Jul 2026, is also its largest on record.
Who backed En Carta Diagnostics first?
En Carta Diagnostics's first round on record, in Jul 2026, was backed by Bpifrance, Ring Capital and 50 Partners.
What stage is En Carta Diagnostics at?
En Carta Diagnostics's latest named round is a Seed, in Jul 2026.
Where is En Carta Diagnostics based?
En Carta Diagnostics is based in France.
Companies like En Carta Diagnostics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.